The classical triad of dysmenorrhea, dyspareunia, and dyschezia occurs in approximately 60% of patients but may not be present early in the disease course (Guo & Wang, 2006)
Hair quality is the second most common surprise
However, for Retatrutide and Tirzepatide, once weekly is the standard that optimizes consistency and practical application in research
Sixty-five patients died as a result of their malignant peripheral nerve sheath tumor, one patient died of high-grade lymphoma, and 49 patients were alive at the last visit (median 32.6 months, range 1.1180 months)
These studies, funded by Novo Nordisk (the maker of Wegovy), showed the best results when the medication was combined with healthy eating and increased physical activity